EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mumps in Poland in 2024

Karolina Mrozowska-Nyckowska, Iwona Paradowska-Stankiewicz

Przeglad Epidemiologiczny · 10.08.2026

DOI: 10.32394/pe/225692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Przeglad Epidemiologiczny, online erschienen am 10.08.2026. Verfasst von Karolina Mrozowska-Nyckowska und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mumps is an acute viral disease transmitted via respiratory droplets, with humans as the only reservoir. Infection spreads easily among children and adolescents, and infectiousness begins before symptom onset. The introduction of MMR vaccination within the mandatory National Immunisation Programme in Poland in 2003 markedly reduced the number of cases and complications.However, surveillance remains essential for evaluating programme effectiveness and the current epidemiological situation.

Objective

To evaluate the epidemiological situation of mumps in Poland in 2024 in comparison with previous years. Material and methods The analysis was based on data published in the annual bulletins: "Infectious diseases and poisonings in Poland in 2024" and "Vaccinations in Poland in 2024" as well as individual case data from the EpiBaza system. Vaccination coverage for the first dose was assessed using data for the 2022 birth cohort (children in their 3rd year of life), and for two doses using data for the 2018 birth cohort (children aged 6 years). Vaccine effectiveness was estimated using the screening method.

Results

In 2024, 931 mumps cases were reported (3.6% decrease vs. 2023: 966). Overall incidence was 2.5 per 100,000 (in 2023: 2.6) and remained below the 2015-2019 median (4.3). The highest incidence was recorded in Śląskie voivodeship (3.7; 159 cases), and the lowest in Opolskie and Warmińsko-Mazurskie voivodeships (1.0). The largest numbers of cases were reported in Mazowieckie (183) and Śląskie (159) voivodeships. Eighteen patients were hospitalised (vs. 12 in 2023). Laboratory testing was performed in 2.1% of cases.

Conclusions

In 2024, a slight decrease in the number of cases was observed, with incidence similar to 2023. Values remained lower than in the pre-COVID-19 period. The increase in case numbers after 2021 may be associated with the restoration of social contacts and transmission of droplet-borne infections. The low proportion of hospitalisations does not indicate increased clinical severity. Continued monitoring of trends and case structure is justified, together with improving the proportion of laboratory confirmation.

Zitieren

APA

Mrozowska-Nyckowska, K., & Paradowska-Stankiewicz, I. (2026). Mumps in Poland in 2024. Przeglad Epidemiologiczny. https://doi.org/10.32394/pe/225692

Vancouver

Mrozowska-Nyckowska K, Paradowska-Stankiewicz I. Mumps in Poland in 2024. Przeglad Epidemiologiczny. 2026. doi:10.32394/pe/225692

BibTeX
@article{MrozowskaNyckowska2026,
  author = {Mrozowska-Nyckowska, Karolina and Paradowska-Stankiewicz, Iwona},
  title = {Mumps in Poland in 2024},
  journal = {Przeglad Epidemiologiczny},
  year = {2026},
  doi = {10.32394/pe/225692}
}
Kostenlos starten →